Director/PDMR Shareholding

RNS Number : 5304J

Circassia Pharmaceuticals Plc

14 April 2020

 

Director/PDMR Shareholding

Oxford, UK - 14 April 2020:  Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 9 April 2020, Ian Johnson, Executive Chairman of Circassia purchased 200,000 Ordinary Shares at a price of 22.85 pence per share, Michael Roller, Chief Financial Officer purchased 200,000 Ordinary Shares at a price of 22.683 pence per share and Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares at a price of 23.2 pence per share.

Following these purchases, Ian Johnson holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company), Michael Roller holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company) and Jonathan Emms holds 600,000 Ordinary Shares (0.16% of the issued share capital of the Company).

Contacts

Circassia Pharmaceuticals plc Ian Johnson Executive Chairman Michael Roller Chief Financial Officer c/o FTI Consulting Peel Hunt LLP (Nominated Adviser and Broker) James Steel / Oliver Jackson Tel:  [phone] finnCap (Joint Broker) Geoff Nash / Alice Lane Tel: [phone] Numis Securities (Joint Broker) James Black / Duncan Monteith Tel: [phone] FTI Consulting Simon Conway / Ciara Martin Tel: [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	1. Ian Johnson 2. Michael Roller 3. Jonathan Emms
2.	Reason for the notification
a.	Position/status	1. Executive Chairman 2. Chief Financial Officer 3. Chief Operating Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Circassia Pharmaceuticals plc
b.	LEI	2138006YAT138TOGA556
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary Shares of 0.08p each GB00BJVD3B28
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	Price(s) Volume(s) 1.  22.85p 2.  22.683p 3.  23.2p 1.  200,000 2.  200,000 3.  300,000
d.	Aggregated information · Aggregated volume · Price	n/a
e.	Date of the transaction	2020-04-09
f.	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

DSHGLGDSCDBDGGS